Medicaid launches May 2026
This "non-pushy" tone resonates deeply with readers who have been overexposed to gimmick-based wellness advertising
While the move should reduce spending in the near term, it will disrupt employees already taking medications like Zepbound and Wegovy, forcing many to seek alternative access routes to maintain treatmentmost notably via the cash-pay market
How Saxenda Works for Weight Loss: GLP-1 Explained Saxenda (liraglutide 3.0 mg) is a prescription medicine licensed in the UK for weight management in adults and adolescents with obesity
It is prepared by compounding pharmacies under their regulatory framework, typically section 503A or 503B of the Federal Food, Drug, and Cosmetic Act
The Evidence: Small studies have shown increases in GLP-1 after yerba mate consumption, but the overall research is in its early stages